Nadine Jackson McCleary (Nadine J McCleary, Nadine McCleary)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Metastatic Colorectal Cancer

Electronic Health Record

Top Venues

Nature medicine

JCO precision oncology

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL-1β and PD-1 with combination chemotherapy reduces systemic myeloid suppression in metastatic pancreatic cancer with heterogeneous effects in the tumor. Cancer immunology research (2024)
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine Jackson McCleary, Kimberley J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi Surana, Matthew B Yurgelun, S Jennifer Wang, Joshua Remland, Lauren K Brais, Naima Bollenrucher, Eugena Chang, Lestat R Ali, Patrick J Lenehan, Igor Dolgalev, Gregor Werba, Cibelle Lima, C Elizabeth Keheler, Keri M Sullivan, Michael L Dougan, Cristina Hajdu, Maya Dajee, Marc R Pelletier, Saloney Nazeer, Matthew Squires, Dafna Bar-Sagi, Brian M Wolpin, Jonathan Andrew Nowak, Diane M Simeone, Stephanie K Dougan
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer immunology research 12 (9) (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Nadine Jackson McCleary, Thomas A Abrams, Jennifer A Chan, Eileen M Regan, Samuel J Klempner, Alison M Hannigan, Joshua Remland, Lauren K Brais, Elizabeth Andrews, Matthew B Yurgelun, James M Cleary, Douglas A Rubinson, Lauren L Ritterhouse, Garrett Maron, Andrew J Aguirre, Jeffrey A Meyerhardt, Emma Gardecki, Jochen K Lennerz, Brian M Wolpin, Peter C Enzinger
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma. Nature communications 15 (1) (2024)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Jim W Doolin, Ellana K Haakenstad, Bridget A Neville, Stuart R Lipsitz, Sunyi Zhang, Jessica L F Cleveland, Semegne Hiruy, Michael J Hassett, Anna Revette, Deborah Schrag, Ethan M Basch, Nadine Jackson McCleary
Feasibility of Weekly Electronic Health Record-Embedded Patient-Reported Outcomes for Patients Starting Oral Cancer-Directed Therapy. JCO clinical cancer informatics 7 (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine (2023)
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Julian M Hess, Kelly P Burke, Vjola Jorgji, Princy Sindurakar, Jonathan Braverman, Arnav Mehta, Tomonori Oka, Mei Huang, David Lieb, Maxwell Spurrell, Jill N Allen, Thomas A Abrams, Jeffrey W Clark, Andrea C Enzinger, Peter C Enzinger, Samuel J Klempner, Nadine Jackson McCleary, Jeffrey A Meyerhardt, David P Ryan, Matthew B Yurgelun, Katie N Kanter, Emily E Van Seventer, Islam Baiev, Gary Chi, Joy Jarnagin, William B Bradford, Edmond Wong, Alexa G Michel, Isobel J Fetter, Giulia Siravegna, Angelo J Gemma, Arlene H Sharpe, Shadhmer Demehri, Rebecca Leary, Catarina D Campbell, Omer Yilmaz, Gad A Getz, Aparna Raj Parikh, Nir Hacohen, Ryan B Corcoran
Combined PD-1, BRAF and MEK inhibition in BRAF V600E colorectal cancer: a phase 2 trial. Nature medicine 29 (2) (2023)
Rachel B Keller, Tali Mazor, Lynette M Sholl, Andrew J Aguirre, Harshabad Singh, Nilay S Sethi, Adam Bass, Ankur K Nagaraja, Lauren K Brais, Emma Hill, Connor J Hennessey, Margaret Cusick, Catherine Del Vecchio Fitz, Zachary Zwiesler, Ethan Siegel, Andrea Ovalle, Pavel Trukhanov, Jason Hansel, Geoffrey I Shapiro, Thomas A Abrams, Leah H Biller, Jennifer A Chan, James M Cleary, Steven M Corsello, Andrea C Enzinger, Peter C Enzinger, Robert J Mayer, Nadine Jackson McCleary, Jeffrey A Meyerhardt, Kimmie Ng, Anuj K Patel, Kimberley J Perez, Osama E Rahma, Douglas A Rubinson, Jeffrey S Wisch, Matthew B Yurgelun, Michael J Hassett, Laura Macconaill, Deborah Schrag, Ethan Cerami, Brian M Wolpin, Jonathan Andrew Nowak, Marios Giannakis
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. JCO precision oncology 7 (2023)
Michael J Hassett, Christine Cronin, Terrence C Tsou, Jason Wedge, Jessica Bian, Don S Dizon, Hannah Hazard-Jenkins, Raymond U Osarogiagbon, Sandra L Wong, Ethan M Basch, Toby Austin, Nadine Jackson McCleary, Deborah Schrag
eSyM: An Electronic Health Record-Integrated Patient-Reported Outcomes-Based Cancer Symptom Management Program Used by Six Diverse Health Systems. JCO clinical cancer informatics 6 (2022)
Nadine Jackson McCleary, William S Harmsen, Ellana Haakenstad, James M Cleary, Jeffrey A Meyerhardt, Zalcberg John, Richard A Adams, Axel Grothey, Alberto F Sobrero, Eric Van Cutsem, Richard M Goldberg, Marc Peeters, Josep Tabernero, Matthew T Seymour, Leonard B Saltz, Bruce J Giantonio, Dirk Arnold, Mace L Rothenberg, Miriam Koopman, Hans-Joachim Schmoll, Henry C Pitot, Paulo M Hoff, Niall C Tebbutt, Gianluca Masi, John Souglakos, Carsten Bokemeyer, Volker Heinemann, Takayuki Yoshino, Benoist Chibaudel, Aimery deGramont, Qian Shi, Stuart M Lichtman
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials. JNCI cancer spectrum 6 (2) (2022)
James M Cleary, Nora K Horick, Nadine Jackson McCleary, Thomas A Abrams, Matthew B Yurgelun, Christopher G Azzoli, Douglas A Rubinson, Gabriel A Brooks, Jennifer A Chan, Lawrence S Blaszkowsky, Jeffrey W Clark, Lipika Goyal, Jeffrey A Meyerhardt, Kimmie Ng, Deborah Schrag, Diane M F Savarese, Christopher Graham, Bridget Fitzpatrick, Kathryn A Gibb, Yves Boucher, Dan G Duda, Rakesh K Jain, Charles S Fuchs, Peter C Enzinger
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial. Cancer 125 (13) (2019)